Omnicell (OMCL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stan Berenshteyn from Wells Fargo maintained a Hold rating on the stock and has ...
Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results